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Imaging of Angiotropism/Vascular 
Co-Option in a Murine Model of 
Brain Melanoma: Implications 
for Melanoma Progression along 
Extravascular Pathways
Laurent A. Bentolila1,2, Roshini Prakash3, Daniela Mihic-Probst4, Madhuri Wadehra5, 
Hynda K. Kleinman6, Thomas S. Carmichael3, Bruno Péault7,8, Raymond L. Barnhill9 & 
Claire Lugassy10
Angiotropism/pericytic mimicry and vascular co-option involve tumor cell interactions with the 
abluminal vascular surface. These two phenomena may be closely related. However, investigations 
of the two processes have developed in an independent fashion and different explanations offered as 
to their biological nature. Angiotropism describes the propensity of tumor cells to spread distantly 
via continuous migration along abluminal vascular surfaces, or extravascular migratory metastasis 
(EVMM). Vascular co-option has been proposed as an alternative mechanism by which tumors cells may 
gain access to a blood supply. We have used a murine brain melanoma model to analyze the interactions 
of GFP human melanoma cells injected into the mouse brain with red fluorescent lectin-labeled 
microvascular channels. Results have shown a striking spread of melanoma cells along preexisting 
microvascular channels and features of both vascular co-option and angiotropism/pericytic mimicry. 
This study has also documented the perivascular expression of Serpin B2 by angiotropic melanoma cells 
in the murine brain and in human melanoma brain metastases. Our findings suggest that vascular co-
option and angiotropism/pericytic mimicry are closely related if not identical processes. Further studies 
are needed in order to establish whether EVMM is an alternative form of cancer metastasis in addition 
to intravascular cancer dissemination.
Mortality from cancer is directly related to its invasion and metastatic potential. Metastasis is defined by end 
points (metastatic lesions detected in specific organs distant from a primary tumor), but the dynamic aspect of 
the metastatic process to distant organs is still a subject of intense interest in cancer biology1. After considerable 
debate about the potential mechanisms of cancer metastasis continuing until the end of the 19th century, the 
intravascular dissemination of cancer was finally accepted and is still widely considered as an exclusive para-
digm1,2. Therefore, the interaction of tumor cells with the tumor vasculature is mainly studied for its role in tumor 
blood supply (tumor angiogenesis) and intravascular metastasis by circulating tumor cells (CTC).
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During intravascular dissemination, intravasation at the primary site of the tumor refers to the entry of tumor 
cells into either the lymphatic or blood circulation. Then, the circulating tumor cells must survive, are passively 
transported in the circulation, arrest in distant organs, extravasate (escape of cells from the circulation), and grow 
to form secondary tumors in the new organ environment1,3.
It has been demonstrated that only a few cells in a primary tumor are able to give rise to a metastasis. This is 
evident since most cancer cells that leave a solid tumor perish before completing all the steps in the metastatic 
process. The majority of the CTC never successfully invade a distant organ but die in the vasculature4, or perish 
when the CTC infiltrate distant organs5. The complexity of this progression explains, in part, why the metastatic 
process was suggested to be inefficient1.
While the propensity for tumor cells to migrate along anatomic structures, such as nerves and skin append-
ages has been recognized for many years6,7 this same capacity of tumor cells to spread along the external vascular 
surfaces had received almost no attention in the literature until recently. This extravascular tumor spread repre-
sents in fact another interaction of tumor cells with vessels in addition to tumor angiogenesis and intravasation. 
During the past 15 years, two fields of research have emerged which emphasize this interaction: 1. Vascular 
co-option; 2. Angiotropism and pericytic mimicry. These two processes potentially may be similar; however, both 
processes have been studied independently and interpreted in entirely different ways. These two different lines of 
investigation have raised important questions about different aspects of the metastatic process.
Vascular co-option, i.e., the use of pre-existent vessels by tumor cells, was first described in the brain. Indeed, 
for a long time it has been suggested that glioblastoma can spread via existing vessels rather than being supplied 
by new ones8,9. The term “co-opting of vessels” was introduced into the literature by Holash et al.10 with the obser-
vation that “In contrast with the prevailing view that most tumors and metastases begin as avascular masses, evi-
dence is presented here that a subset of tumors instead initially grows by co-opting existing host vessels.” Histological 
examination of vascular co-option by glioma cells have shown organization of tumor cells into cuffs around 
normal microvessels11. More recently, it has been demonstrated that during vascular co-option in lung metastases 
tumor cells anchor themselves to the endothelial basement membrane of vascular channels12.
This research questioned the long-standing concept that all solid tumors are dependent on angiogenesis, i.e., 
the formation of new vessels, for the sustained growth of tumors and metastasis, which had acquired a central 
position in cancer research13. Therefore, the proposed pathobiological significance of vascular co-option is that 
tumors may utilize alternative mechanisms in addition to angiogenesis in order to obtain a blood supply. Thus, 
tumors may initially develop without the need for an angiogenic switch14,15.
Finally, according to the recent study of Valiente et al. another biological role of vascular co-option is to 
protect cancer cells from death signals generated by plasmin16. Using brain colonization assays via intracardiac 
injection of fluorescent tumor cells (by-passing intravasation of tumor cells), this study demonstrated that tumor 
cells express plasminogen inhibitors serpins, including serpin B2, in order to promote cancer cell survival and 
vascular co-option.
In contrast, over the past 15 years Lugassy and Barnhill have drawn attention to angiotropism as a important 
biological phenomenon, particularly in melanoma17–20. Angiotropism is defined histologically as tumor cells dis-
posed along the external, abluminal surfaces of vessels in a pericytic location without intravasation17. Since the 
first description of angiotropism, it was emphasized that angiotropic melanoma cells were linked to the endothe-
lium by an amorphous basement membrane containing laminin18. Angiotropism is optimally recognized either 
at the invasive front of the tumor or in nearby tissues. Angiotropism promotes pericytic mimicry, the spreading 
of tumor cells along the abluminal vascular surfaces of microvessels, as demonstrated in different in vitro and in 
vivo models18,19. Using our 3D co-culture model of angiotropism and pericytic mimicry18, we also showed that the 
interaction between melanoma cells and endothelial cells triggered differentially expressed genes associated with 
cancer progression. Among these genes, 10 were also linked to inflammation, including SERPIN B2. Interestingly, 
our recent work demonstrated that inflammation promotes angiotropism, pericytic mimicry, and metastasis in a 
genetically engineered murine melanoma model18, confirming again the importance of angiotropism and peri-
cytic mimicry in both melanoma progression and metastasis.
Research on angiotropism has questioned the assumption that all tumor cells use exclusively intravascular 
dissemination for the formation of metastasis. The main proposed pathobiological significance of angiotropism is 
that tumor cells have the propensity to spread via continuous migration along the abluminal vascular surfaces or 
other tracks to nearby or more distant sites, without entering into vascular channels. This alternative mechanism 
of tumor spread, distinct from intravascular dissemination, has been termed extravascular migratory metastasis 
or EVMM20. Current data have shown that tumor cells manifest angiotropism to both microvessels and larger 
vessels18; however the involvement of mature and perfused microvessels versus neovessels still requires further 
investigation.
In the present work, we have used a murine brain melanoma model, in which tumor cells are injected directly 
into the brain as a primary site of tumor development. We have analyzed 3D images obtained during the progres-
sive interaction of green fluorescent tagged melanoma cells with red fluorescent lectin tagged vessels. We have 
investigated the implication of mature vessels versus neovessels in tumor spreading along vessels. We have also 
examined the expression of Serpin B2 in this murine brain melanoma model, as well as in a series of human mela-
noma brain metastases. Our goal was to investigate the similarities between vascular co-option and angiotropism, 
and to discuss the significance of these mechanisms during the metastatic process.
Results
Angiotropic dissemination of human melanoma cells in the mouse brain. In order to characterize 
the capacity of tumor cells to spread along external vascular surfaces, we examined early stages of brain tumor 
formation after injecting human melanoma cells directly into the brain of immuno-compromised Nu/J mice. 
Examination over time revealed conspicuous tumor growth of the GFP-labeled melanoma cells at the injection 
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site (Fig. 1 and S1). In addition, we observed a striking spread of melanoma cells emanating from the tumor mass. 
High resolution confocal fluorescence imaging revealed that this tumor spread had a preferential association 
with the abluminal surfaces of the microvascular channels (the vascular endothelium being clearly delineated by 
the red fluorescent lectin) from the earliest time point at 1 week to 4 weeks after injection (Fig. 2). While single 
melanoma cells were seen to elongate along blood microvessels at the advancing front of the tumor (Fig. 2), 
they formed small clusters or larger groups of cells along the vascular plexus (Figs 1 and 3). These cells exhibited 
lengthy fine cellular processes extending along the surfaces of the vascular channels. Ramifying vascular channels 
showed melanoma cells spreading along these branching vessels (Figs 1 and 2). All angiotropic tumor cells were 
spreading along lectin positive vessels. GLUT1 staining did not reveal additional vessels covered by tumor cells 
(data not shown).
These results demonstrate the angiotropic nature of the metastatic tumor cell growth which occurs preferen-
tially in close association with the existing brain microvasculature.
Angiotropic dissemination occurs without evidence of intravasation. We further asked whether 
the association of tumor cells with vessels far away from the tumor mass could be attributed to tumor cells migrat-
ing inside the microvasculature. Figure 3 shows a representative 3D analysis of a large group of elongated mel-
anoma cells wrapped around a blood vessel at four weeks post-implantation. One can clearly observe that all 
GFP-labeled melanoma cells are exclusively external to the vessels, and that there was no evidence of either intra-
vasation or the presence of intra-luminal tumor cells (Fig. 3B and Supplementary Movie S1).
These results demonstrate that this angiotropic dissemination does not depend on cells circulating through 
the blood supply but rather must be primarily due to the migration of the tumor cells along the external walls of 
the brain microvessels.
Expression of Serpin B2 correlates with tumor cell spreading along microvasculature. We then 
investigated Serpin B2 expression given its important role in cancer survival and brain metastasis15. Figure 4 
shows striking abluminal expression of Serpin B2 in a pattern largely superimposable with that of GFP-labeled 
melanoma cells. The merged images showed prominent localization of Serpin B2 to the angiotropic melanoma 
cells (Fig. 4D,E).
We further extended our analysis to specimens of human melanoma brain metastases from patients with pri-
mary cutaneous melanoma. Among 15 human melanoma brain metastases, 5 showed immunohistochemical 
expression of SERPIN B2. This expression was observed in an angiotropic distribution focally in all 5 specimens 
(Fig. 5A). This expression was strong in two of the 5 specimens, and in one of these the pattern of expression was 
focally diffuse in the melanoma cell population. In contrast, the expression was recorded as relatively weak in 3 
cases. It should be noted that some of these 15 brain specimens exhibited some degree of tissue necrosis in areas 
which precluded complete microscopic interpretation. Moreover, the spatial distribution of tumor spread in the 
present study is strikingly similar to a previously reported example of human melanoma metastatic to the brain 
with florid angiotropism23 (Fig. 5B).
Altogether, these results validate the clinical relevance of our mouse model and emphasizes the role of Serpin 
B2 in angiotropic tumor cell migration in the brain.
Motility of angiotropic melanoma cells in the mouse brain. We have further assessed the motility of 
the angiotropic melanoma cells by scoring the total distance traveled away from the tumor mass over time (Figs 1 
and 6). The average migration along vessels observed was 71 μm at one week, 183 μm at two weeks, and 581 μm 
at four weeks (Fig. 6). No GFP tumor cells were observed neither in the lungs nor in the liver (data not shown).
Discussion
In the present study, we have observed that melanoma cells implanted in the brain of nude mice spread some 
distance along the abluminal surface of blood vessels over a period of one to four weeks post-implantation. 
Importantly, vessels implicated in this tumor progression are functional, preexisting blood vessels, and not newly 
formed vessels, which is an attribute associated with vascular co-option14. Indeed, all tumor cells were associated 
with lectin-stained vessels, which were in fact perfused vessels with lumina22. Furthermore, the images of tumor 
spread in the present study closely resembled a previously reported example of human melanoma metastatic to 
the brain with conspicuous angiotropism23 (Fig. 5B). The present data also concur with observations from several 
in vitro and in vivo models of pericytic mimicry, showing the spread of tumor cells along vessels over time18,19.
This study also documented perivascular expression of Serpin B2 by angiotropic melanoma cells in the murine 
brain (Figs 4 and 5). SERPIN B2 was also positive in 33% of the brain melanoma metastases from patients with 
primary cutaneous melanoma (Fig. 5A). The latter results correspond to the data of Valiente et al. in human brain 
metastases from breast cancer among which 34% of the samples were positive for SERPIN B216. These authors did 
not describe a specific tissue localization of tumor cells expressing SERPIN B2 in the human samples, while in our 
study, human brain metastatic melanoma cells positive for SERPIN B2 were clearly angiotropic (Fig. 5). Notably, 
almost all of these human brain specimens were small partial biopsy samplings without a clear advancing front, 
where angiotropism is most easily and commonly detected. Also because of the frequent presence of necrosis and 
tissue ischemia in brain samples, it is possible that SERPIN B2 expression by angiotropic melanoma cells may 
have been present in a greater number of specimens.
Serpin B2 (also known as plasminogen activator inhibitor type 2 or PAI-2) is a member of the serpin super-
family. The physiological function of Serpin B2 in vivo has remained elusive24. It has recently been shown that 
“by protecting cancer cells from death signals and fostering vascular co-option, anti-PA serpins including serpin B2 
provide a unifying mechanism for the initiation of brain metastasis in lung and breast cancers”16. Serpin B2 is also 
www.nature.com/scientificreports/
4Scientific RepoRts | 6:23834 | DOI: 10.1038/srep23834
commonly upregulated by inflammation, and a recent study has demonstrated that neutrophilic inflammation 
promotes angiotropism, pericytic mimicry, and metastatic spread in a genetically engineered melanoma murine 
model18. Interestingly, the interaction between melanoma cells and the abluminal surfaces of endothelial tubules 
in vitro induces significant over expression of Serpin B2, even when plasmin and inflammation are absent25.
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Figure 1. Tumor formation and progressive angiotropic dissemination by human C8161 melanoma cells 
in the mouse brain. GFP C8161 melanoma cells (green) were stereotaxically injected into the cerebral cortex 
of Nu/J immuno-compromised mice. The animals were subsequently perfused with Lectin-Dylight 594 (brain 
microvessels, red) just before being sacrificed at one week (A), two weeks (B) or four weeks (C). The panels on 
the left show representative coronal sections of one mouse brain hemisphere at these various time points. The 
panels on the right show fields with increased magnification of the hatched inset areas from the corresponding 
left panels, with arrows showing angiotropic spread by human melanoma cells. (A) After one week, tumor 
growth of GFP melanoma cells is clearly visible at the injection site (asterisks). Melanoma cells are starting 
to spread along the abluminal surfaces of the microvascular channels emanating from the tumor mass (right 
panel, arrows). (B) After two weeks, the progressive spread of melanoma cells along the microvascular channels 
extends far beyond the tumor mass. (C) At four weeks, radiating spread of melanoma cells some distances from 
the injection site along the microvascular channels (arrows) demonstrating strong association with Lectin 
positive blood vessels (red). White arrows indicate direction of tumor progression. Note that at each time point, 
melanoma cells were disposed as single cells at the advancing front of the tumor (See also Supplementary Figure 
S1: tumor growth). Scale bars, 1 mm.
www.nature.com/scientificreports/
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Although this study involved the brain exclusively as a primary organ for imaging vascular co-option and 
angiotropism, it is important to emphasize that vascular co-option and angiotropism are observed in many organs 
affected by different types of primary and metastatic cancers26–29. Finally, several data suggest that resistance and 
recurrence to current therapies could be linked to angiotropism and vascular co-option30–33.
Taken together, the similarities between vascular co-option and angiotropism/pericytic mimicry strongly sug-
gest that these two phenomena are closely related if not identical.
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Figure 2. Angiotropism of human melanoma cells in the murine brain tumor. The left panels show 
representative images of the progression of C8161-induced tumor (green) in coronal sections at one week (A), 
two weeks (B) and four weeks (C) after injection. The right panels show a magnification of the hatched inset 
areas from the corresponding left panels. Insets on the right are images of vessels (red) in the absence of the 
green channels (i.e. the tumor melanoma cells). (A) Note initial sprouting of melanoma cells (green) beyond 
the solid tumor mass as single cells and spreading along the abluminal surfaces of the microvessels (red). This 
might be termed “the advancing front” of the tumor. On can discern empty vascular lumina with no evidence 
of intravascular localization of tumor cells. (B) Comparable image of GFP-labeled melanoma cells associated 
with microvascular channels at two weeks. The GFP-labeled melanoma cells are spreading along the abluminal 
surfaces of the microvessels some distance away from the tumor mass. (C) At four weeks, the spreading of 
melanoma cells has continued some distance beyond from the tumor mass while remaining confined to the 
external surfaces of endothelial cells. White arrows indicate direction of tumor progression. Scale bars, 100 mm.
www.nature.com/scientificreports/
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Indeed, a number of terms and descriptions introduced into the cancer research literature may in fact 
be closely related processes, rather than representing new or original observations. For example, another 
closely-related phenomenon described with new terminology and interpretation is that of “Glioblastoma stem 
cells generate vascular pericytes to support vessel function and tumor growth”34. In an earlier study entitled 
“Pericytic-like angiotropism of glioma and melanoma cells”, we previously described similar findings emphasizing 
the migratory nature of these tumor cells in a pericytic manner30,35,36. On the other hand, Cheng et al. proposed 
the role of glioma stem cells as pericyte progenitors, and suggested that they may contribute to the formation of 
tumor vasculature and the promotion of tumor growth34.
Cancer stem cells or cancer cells with stem/embryonic properties are often described as vascular niches, 
which represents the topography of vascular co-option and angiotropism37,38. The conspicuous analogies between 
EVMM and embryonic migration39, especially migration of neural crest cells along vessels in the embryo40,41 
suggests that EVMM in melanoma may recapitulate stem/embryonic cell migration in order to reach secondary 
sites18,33.
Cancer cells may express a broad spectrum of migratory and invasive properties and are able to modify their 
migration behaviour in response to changing conditions42–44. In the case of migration along vascular tracks, vas-
cular co-option/angiotropism was observed as early as one week in the present brain melanoma model. After 
four weeks, about 581 μm of brain tissue was traversed by tumor cells migrating along the vascular surfaces. Such 
distances of travel represent an average velocity of 21 μm per day. Such figures are compatible with a collective 
migration (0.01–0.05 μm/min)44, corresponding to our observations of groups of cells spreading along the exter-
nal vascular surfaces (Fig. 3).
In addition to angiotropism and vascular co-option, other forms of extravascular migration of melanoma 
cells, such as invasion of nerves (neurotropism) and skin adnexal structures, i.e., hair follicles and eccrine sweat 
ducts (adnexotropism), have been recognized for many years7. Furthermore, Friedl and co-workers have demon-
strated that a variety of anatomic tissue structures may guide the invasion of tumor cells for considerable dis-
tances in tissue. Examples include the peritoneum, pleura, and brain ventricles. In addition to vessels and nerves, 
other structures ensheathed by a basement membrane, such as myofibers and adipocytes, may be used as a scaf-
folding for cancer cell migration. Other anatomic structures utilized as tracks are collagen fibers, bone cavities, 
and the choroid plexus and glia limitans in the brain43. In the present murine model, no lung or liver metastases 
were detected. If EVMM occurs in addition to intravascular migration, tumor cells would require more than four 
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Figure 3. Interactions of tumor cells with the brain microvasculature. (A) 2D maximum intensity 
projections of 70 confocal z-stack images for each two separate channels: melanoma cells (top panel, green) 
and blood vessels (middle panel, red) at four weeks post-implantation. Lower panel: overlay of melanoma 
cells and blood vessels. Note large groups of elongated melanoma cells enveloping the vascular endothelial 
surfaces along the vascular plexus. (B) A single z-slice is shown in the middle panel. The crosshair indicates 
the position of the XZ cross-section and the ZY cross-section shown on the two side panels. The melanoma 
cells are entirely external to the red Lectin-labeled endothelial cells confirming that melanoma cells are arrayed 
about the abluminal endothelial surfaces and that the intraluminal space does not contain tumor cells (See also 
Supplementary Movie S1: 3D animation). White arrow indicates direction of tumor progression. Scale bars, 
50 mm.
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weeks to reach such distant sites. This latency in such a vital organ may be one reason why metastases of primary 
brain malignancies are rarely reported before patient death45.
Extravascular migration of tumor cells is generally considered to precede intravasation42 or to follow extrava-
sation16, and therefore before or after the process of intravascular dissemination of CTC. However, via utilization 
of the different kinds of extravascular routes described above, a continuous migration of melanoma (and other 
tumors) could constitute an alternative mechanism of tumor spread distinct from intravascular dissemination or 
EVMM46. Via this mechanism, tumor cells could spread to nearby, or to more distant sites, without entering vas-
cular channels, representing a veritable alternative metastatic pathway to “the inefficient intravascular metastatic 
process”1.
If angiotropism and vascular co-option are similar -if not identical- phenomena demonstrating tumor spread 
along the abluminal surfaces of vessels, they also represent two very different concepts. In the case of vascular 
co-option, the uniqueness of the intravascular mechanism of metastasis is implicitly assumed. On the other hand, 
the concept of angiotropism and pericytic mimicry raises the possibility and likelihood of an alternative mech-
anism of dissemination. The field of pericytic mimicry and other extravascular forms of tumor cell migration 
clearly mandates much more research as to the relative importance and/or the reality of extravascular migratory 
metastasis (EVMM) in melanoma (and other malignancies) progression versus intravascular dissemination. A 
full understanding of how metastases develop from the primary cancer would have major implications for the 
design of effective therapies.
Methods
Cell line. The C8161 GFP human melanoma cell line21 was kindly provided by Dr. Danny Welch (The Kansas 
University Medical Center).
Intracranial tumor implantation. Ethical Treatment of Animals Statement. This study was carried out 
in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the 
National Institutes of Health. The protocol was approved by the Animal Research Committee at the University of 
California, Los Angeles, and all efforts were made to minimize animal suffering.
Six to eight-week-old BALB/c nude female mice were obtained from Charles River Laboratories (Wilmington, 
MA). In order to implant tumors, mice were anaesthetized using a mixture of isoflurane and oxygen under a 
steady flow. The mice were then mounted on a stereotaxic frame (Kopf Instruments) with a maintenance dose 
of anesthesia (2% isoflurane and oxygen). The skin on top of the head was prepared for surgery with alternate 
applications of alcohol and povidone iodine and then incised along the midline and retracted. Melanoma cells 
(105 cells/μl in a suspension of L-15 medium) were injected through stereotactic pneumatic injection with 
Hamilton syringes at a flow rate of 0.25 μl/min. Tumor cells were injected at each of three stereotactic coordinates 
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Figure 4. Association of Serpin B2 with human melanoma cells in the murine brain. Immunohistochemistry 
was performed on coronal sections at two weeks. (A) GFP-labeled melanoma cells (green) spreading distally along 
the abluminal surfaces of the (B) microvascular channels (red) from the tumor growth. (C) Immunohistochemistry 
for expression of Serpin B2. (D) Overlay of the three images above. (E) Magnification of the hatched inset areas 
from (D) showing the strong co-localization of Serpin B2 to the abluminal melanoma cells. White arrow indicates 
direction of tumor progression. Scale bars, 50 mm.
www.nature.com/scientificreports/
8Scientific RepoRts | 6:23834 | DOI: 10.1038/srep23834
(anteroposterior (AP) = 1.36, medial lateral (ML)  = 1.07, and dorsal ventral (DV) − 0.75) in both hemispheres 
(six injection per mouse). Before injection the needle was pushed up to 0.5 mm more than the DV coordinate to 
create a space. At the completion of implantation the needle was drawn out slowly after a delay of 5 minutes. The 
skin was re-sealed using tissue adhesive, and the animals were allowed to recover. Tumors were allowed to grow 
for 1, 2, and 4 weeks post injection in three separate cohorts of two mice each, resulting in 12 tumors per time 
point.
Visualization of brain vasculature. Before imaging, animals were anaesthetized with ketamine/ xyla-
zine mixture and placed in the supine position and a small incision was made between the neck and shoulder. 
The jugular vein was exposed for injection of 100 μl of Dylight 594 conjugated Tomato Lectin (1mg/ml) (Vector 
Laboratories, CA). The lectin was allowed to circulate for 8–10 min after which the animal was sacrificed.
Tissue processing and immunofluorescence. After whole brain extraction and fixation in 4% para-
formaldehyde for 24 h followed by incubation in 30% sucrose in phosphate-buffered saline, 50 μm sections were 
used for examination with ultra-confocal microscopy. Lungs and livers were also obtained for microscopic exam-
ination. For immunofluorescence studies, 50 μm sections were rinsed twice in phosphate buffered saline, pH 7.4 
(PBS), and placed in 10 mM sodium citrate buffer, pH 8.5, for 30 min at 80 °C for antigen retrieval. Following 3 
brief washes in PBS, sections were then blocked and permeabilized in 10% normal donkey serum containing 
0.3% Triton X-100 for 30 min and transferred to MOM block (Vector Labs) for 1 hr at room temperature (RT). 
After 3 additional washes in PBS, primary antibody cocktails were diluted in blocking solution and left over-
night at RT. The following antibodies were used: antibodies against Serpin-B2 at 1:200 (PAI-2 Antibody: sc-6649 
Santa Cruz Biotechnology) and Glut-1 at 1:500 (400060-50UG, EMD Millipore) according to the manufacturers’ 
instructions.
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Figure 5. Angiotropism and Serpin B2 in human brain melanoma metastases. (A) Human brain melanoma 
metastasis showing striking expression of SERPIN B2 (dark red) by melanoma cells predominately disposed 
along the abluminal surfaces (angiotropism) of microvascular channels (Asterisks). (B) Montage of mouse 
brain melanoma spread and metastatic melanoma in the human brain. Lower left image shows GFP-labeled 
melanoma cells spreading along red lectin-labeled microvascular channels, as shown in the preceding images. 
Upper right H & E image depicts human melanoma cells disposed along the abluminal surfaces of vascular 
channels in metastatic melanoma to the brain. The melanoma cells are identified by significant cytoplasmic 
melanin content and conspicuous cytological atypia. Evidence of intravascular melanoma cells was not 
identified. Note the conspicuous angiotropism of tumor cells in a pericytic location in both images (green 
melanoma cells in the murine brain model, melanoma cells containing melanin pigment in the human sample). 
Scale bars 50 μm.
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Fluorescence imaging. Full frame coronal brain slices of 50 μm thickness were imaged with a Leica 
DM6000 inverted fluorescence microscope (Leica Microsystems, Wetzlar, Germany) equipped with a DFC365 
FX CCD camera, green and red filter cubes (Green cube: excitation 450–490 nm BP, dichroic 510 nm, emission 
515 nm LP; Red cube: excitation 515–560 nm BP, dichroic 580 nm, emission 590 nm LP) and a 10x/0.3 dry objec-
tive (HC PL FLUOTAR 10x/0.3 dry). High resolution imaging was performed by fluorescence confocal micros-
copy using Leica TCS SP5 and SP8 (Leica Microsystems, Wetzlar, Germany) inverted confocal laser scanning 
microscopes equipped with a 40x/1.25NA oil objective (HCX PL APO CS 40.0 × 1.25 oil) and a 63x/1.40NA oil 
objective (HC PL APO CS2 63.0X/1.40 oil). Fluorescent protein and immunofluorescence stains were excited 
sequentially with visible lasers (GFP: 488 nm, Dylight594: 594 nm, Atto647: 633 nm). Scanning was performed at 
a line frequency of 400 Hz with an image format of 1024 × 1024 pixels. Each frame was averaged 4 times.
Image processing. Registration and mosaicking of hundreds of individual images to form one large full 
frame image of the coronal brain sections was performed with the LAS AF software (Leica Microsystems, Wetzlar, 
Germany). High resolution images were analyzed, processed and visualized in 3D using the LAS X software 
(Leica Microsystems, Wetzlar, Germany).
Measure of the maximum angiotropic migrated distance. Coronal sections at each time point were 
scored for the presence of tumor cells growing in direct adhesion to the blood vessel exterior walls. Distances were 
measured from the margin of the tumor mass to the deepest connected tumor infiltration spreading along vessels.
SERPIN B2 immunostaining of human metastatic melanoma to the brain. This study was carried 
out in strict accordance with the relevant guidelines and regulations provided by the ethical authorities of the 
Canton Zurich. All immunohistological experimental protocols were approved by the official ethical authorities 
of the Canton Zurich (StV 16-2007, Amendment 2014). Informed consent was obtained from all subjects.
Fifteen cases with melanoma metastatic to the brain were retrieved from the archives of the Department of 
Pathology, University Hospital Zurich. These studies were approved by the Institutional Review Board, UHZ. 
These specimens were examined for angiotropism and SERPIN B2 expression. Two μm sections were stained with 
polyclonal rabbit antibody against SERPIN B2 at 1:50 (PAI-2: H-70; Santa Cruz sc-25745). Immunohistochemical 
staining was performed on automated immunostainer Bond/Leica (Vision BioSystems Ltd, Newcastle Upon 
Tyne, UK).
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